Peritoneal metastases are often the first presentation of ovarian malignancy. Evaluating the extent of disease critically determines tumor resectability and can also predict outcome. Standard CT ...

If levels are high, peritoneal or ovarian cancer may be present. But CA-125 can be high for other reasons. So, this test cannot confirm a diagnosis of these cancers. CT scan.

Bio-Thera Solutions has initiated dosing in the randomised Phase III trial of the antibody-drug conjugate (ADC), BAT8006, ...

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

Peritoneum is the most common site for ovarian cancer metastasis. Here we investigate how cancer epigenetics regulates reciprocal tumor-stromal interactions in peritoneal metastasis of ovarian cancer.

Ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer is a disease in which cancerous cells form in the tissues covering the ovary or lining the fallopian tube or peritoneum.

Peritoneal cancer is a rare cancer that ... The procedure also risks seeding the abdominal wall ... Halkia E, et al. (2018). Update on ovarian cancer peritoneal carcinomatosis multimodal ...

Cancers originating from organs in the peritoneal cavity (e.g., ovarian, pancreatic, colorectal, gastric and liver) account for approximately 250,000 new cancer cases annually in the USA ...

Stage II ovarian cancer. The cancer has spread to nearby areas of your pelvis. Experts divide this stage into two substages. In stage IIA, your cancer has spread to your uterus.

American Cancer Society. Ovarian cancer statistics: How common is ovarian cancer.American Cancer Society. 2024.; Fishman DA, et al. Production of extracellular matrix-degrading proteinases by primary ...

An ovarian biopsy is an important stage in the diagnostic process to confirm ovarian cancer. There are several ways to take a biopsy, depending on a person’s health status and likely cancer stage.

Background: Epithelial ovarian cancer (EOC) is characterized by chemoresistant recurrences primarily confined to the intraperitoneal cavity, frequently leading to malignant small bowel obstructions.